Andrew Fromkin Joins as New President and Chief Executive Officer Michael Metzger to Join as New…
Continue ReadingTag: radius-health
Radius Health Completes $43 Million Financing to Advance BA058 for the Treatment of Osteoporosis
Board Appoints New Members, Morana Jovan-Embiricos, PhD and Owen Hughes
Continue ReadingRadius Health to Present at Cowen & Company 33rd Annual Health Care Conference in Boston
CAMBRIDGE, MA -- (Marketwire) -- 02/26/13 -- Radius Health, Inc. ("Radius"), a biopharmaceutical company focused on…
Continue ReadingRadius Health to Present at BIO CEO & Investor in New York
CAMBRIDGE, MA -- (Marketwire) -- 02/08/13 -- ("Radius"), a biopharmaceutical company focused on developing new therapeutics…
Continue ReadingRadius Provides Update on Pivotal Phase 3 Program for BA058-SC Injection
CAMBRIDGE, MA -- (Marketwire) -- 01/07/13 -- ("Radius"), a biopharmaceutical company focused on developing new therapeutics…
Continue ReadingRadius Health Withdraws Registration Statement
CAMBRIDGE, MA -- (Marketwire) -- 11/15/12 -- ("Radius"), announced today that it has voluntarily withdrawn its…
Continue ReadingRadius Health Announces Upcoming Scientific Presentations at ENDO 2012, the Endocrine Society-s 94th Annual Meeting
CAMBRIDGE, MA -- (Marketwire) -- 06/22/12 -- Radius Health, a development-stage biopharmaceutical company focused on advanced…
Continue ReadingRadius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing
CAMBRIDGE, MA -- (Marketwire) -- 12/16/11 -- Radius Health, Inc. ("Radius") announced today the closing of…
Continue Reading